MedPath

BioNTech Research & Development, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Phase 1
Terminated
Conditions
Tumors That Express CA 19-9
Pancreatic Carcinoma
Interventions
First Posted Date
2017-04-18
Last Posted Date
2023-04-21
Lead Sponsor
BioNTech Research & Development, Inc.
Target Recruit Count
4
Registration Number
NCT03118349
Locations
🇺🇸

HonorHealth Research Institute, Scottsdale, Arizona, United States

🇺🇸

MSKCC, New York, New York, United States

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Phase 1
Terminated
Conditions
Pancreatic Carcinoma
Tumors That Express CA19-9
Interventions
First Posted Date
2016-02-22
Last Posted Date
2021-08-31
Lead Sponsor
BioNTech Research & Development, Inc.
Target Recruit Count
15
Registration Number
NCT02687230
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies

Phase 1
Terminated
Conditions
Pancreatic Cancer
Interventions
Drug: modified FOLFIRINOX (mFOLFIRINOX)
First Posted Date
2016-02-03
Last Posted Date
2025-01-28
Lead Sponsor
BioNTech Research & Development, Inc.
Target Recruit Count
264
Registration Number
NCT02672917
Locations
🇺🇸

HonorHealth Research Institute, Scottsdale, Arizona, United States

🇺🇸

The Angeles Clinic & Research Institute, Los Angeles, California, United States

🇺🇸

Florida Cancer Specialist and Research Institute, Sarasota, Florida, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.